Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 4/20 | 0.41 |
| ▸ | PIK3C3 | Q8NEB9 | 3/20 | 0.36 |
| ▸ | HPGDS | O60760 | 5/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.33 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.32 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ATP4A | P20648 | 1/20 | 0.31 |
| ▸ | ATP4B | P51164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4592678 | 0.86 | AKT1 (0.46) | AKT1PIK3C3HPGDSCYP2C19KLKB1 | |
| SCHEMBL4584230 | 0.83 | AKT1 (0.48) | AKT1PIK3C3CYP2C19 | |
| SCHEMBL8233993 | 0.80 | AKT1 (0.45) | AKT1PIK3C3HPGDS | |
| SCHEMBL8243099 | 0.79 | AKT1 (0.47) | AKT1HPGDSL3MBTL1 | |
| SCHEMBL4633196 | 0.79 | CYP2C19 (0.46) | PIK3C3CYP2C19ENPP3ENPP1L3MBTL1 | |
| SCHEMBL4583850 | 0.78 | AKT1 (0.67) | AKT1HPGDS | |
| SCHEMBL8242925 | 0.72 | PIK3C3 (0.42) | AKT1PIK3C3CYP2C19ENPP3ENPP1 | |
| SCHEMBL4541679 | 0.72 | AKT1 (0.41) | AKT1HPGDS | |
| SCHEMBL10125007 | 0.72 | L3MBTL1 (0.44) | PIK3C3ENPP3PTGDR2L3MBTL1 | |
| SCHEMBL4592495 | 0.72 | AKT1 (0.46) | AKT1PIK3C3CYP2C19KLKB1ENPP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1968568-A2 | INHIBITORS OF Akt ACTIVITY | SmithKline Beecham Corporation (US) | 2008-09-17 | — | — | EP | disclosed |
| WO-2007076423-A2 | INHIBITORS OF Akt ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2007-07-05 | — | — | WO | disclosed |